CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 P&L / Income Statement
2025-12-28 to 2026-06-27
Revenue by Product and Service
2025-12-28 to 2026-06-27
Swipe to see the full flow
Chart details
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 P&L / Income Statement
Income statement for 2025-12-28 through 2026-06-27. View: Product and service. Revenue and costs use their disclosed categories.
- Total revenue
- 1,999,908,000 US dollars
- Cost of revenue (calculated)
- 1,341,870,000 US dollars
- Gross profit (calculated)
- 658,038,000 US dollars
- Operating expenses (calculated)
- 418,253,000 US dollars
- Operating income
- 239,785,000 US dollars
- Other income (expense), net (calculated)
- negative 216,557,000 US dollars
- Income before income taxes
- 23,228,000 US dollars
- Provision for income taxes
- 38,790,000 US dollars
- Net income (loss)
- negative 15,562,000 US dollars
- Service revenue
- 1,606,439,000 US dollars
- Product revenue
- 393,469,000 US dollars
- Service cost of revenue
- 1,160,914,000 US dollars
- Product cost of revenue
- 180,956,000 US dollars
- Amortization of intangible assets
- 29,934,000 US dollars
- Selling, general and administrative
- 388,319,000 US dollars
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
32.9%
Gross profit / revenue
Operating margin
12.0%
Operating profit / revenue
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
